Detection of atherosclerotic plaques by MRI and optical images

01 January 2017 → 30 June 2021
European funding: various
Research disciplines
  • Medical and health sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
atherosclerotic plaques
Other information
Project description

Universities, hi-tech clusters, hospitals and research centres from the France-Belgium cross-border region have joined forces to develop new, non-invasive ways to diagnose atherosclerosis. Atherosclerosis is the narrowing of the arteries due to the build-up of fatty material known as plaque. It causes diseases of the circulatory system – including strokes and heart attacks – which are the leading cause of morbidity and mortality in developed countries. The NanoCardio project explores the use of magnetic (MRI) and optical (fluorescence) imaging to detect the disease in its early stages.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Regional Development Fund, ERDF. Neither the European Union nor the authority can be held responsible for any use the may be made of the information contained therein.